Sorry if question has been asked I searched, but am now more confused. Husband was dx with stage 3b on 12/10 at 39yrs old. Started clinical trial Chemo alimta/ carboplatin every 3 wks with Erbitux weekly. After 5 treatments he stopped and was then placed on Tarceva. Last pet scan 11 days ago showed progression, however, it is all still located within the left lung. What are your thoughts on Anti-KIR Antibody in combination with an Anti-PD1 trial -vs- Tarceva, with alimta, carboplatin and avastin? Aside from the cancer and sometimes HBP and lower back pain he is healthy. He has a severe rash on his hands and 3 toes from the Tarceva and a little bit on his forearms as well.
Sat, 07/20/2013 - 17:45#1
Advanced NSCLC4 after 2yr6mo on Tarceva - 1258100